Vraylar 4.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3GU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,816
Award facts
- Contract value 100% obligated
- $25,815.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,815.54 to AmerisourceBergen Drug Corp for the supply of Vraylar 4.5 mg capsules (30-count units) under a firm fixed-price contract. The award was made on January 13, 2026, with an ultimate completion date of January 14, 2026, and represents a non-competitive delivery order issued without set-aside designation. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal medical procurement.
This delivery order operates under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This comprehensive pharmaceutical prime vendor contract enables the delivery of a broad range of medications, medical supplies, and specialized healthcare commodities to support military treatment facilities and veteran healthcare programs globally. AmerisourceBergen's substantial federal contracting presence and established capacity for pharmaceutical distribution across multiple therapeutic domains position it as a critical vendor within the Defense Health Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FG3GU?
SPE2DR26FG3GU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FG3GU worth?
The government has obligated $25,816 on SPE2DR26FG3GU.
Is contract SPE2DR26FG3GU an order under another contract?
Yes. SPE2DR26FG3GU is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3GU competed?
The extent of competition for SPE2DR26FG3GU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award